Literature DB >> 15030978

Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin.

Agustín Albillos1, Antonio de la Hera Ad, Eduardo Reyes, Jorge Monserrat, Leticia Muñoz, Mónica Nieto, Alfredo Prieto, Eva Sanz, Melchor Alvarez-Mon.   

Abstract

BACKGROUND/AIMS: To investigate the distribution and activation state of circulating monocytes and T-cell subsets, their contribution to tumour necrosis factor-alpha (TNFalpha) production, and their potential relationship with bacterial products of enteric origin in alcoholic cirrhosis.
METHODS: Peripheral blood monocytes and T-lymphocytes from 60 cirrhotic patients and 24 controls were characterized by four-color flow-cytometry after labelling of differentiation antigens and cytokines, before and after a 4-week course of norfloxacin or placebo.
RESULTS: Monocytes from ascitic patients showed increased number, enhanced CD80 and HLA-DR surface levels, and spontaneous intracytoplasmic TNFalpha expression, when compared to non-ascitic patients and controls. Blood TNFalpha levels directly correlated with the amount of TNFalpha expressed by monocytes. In ascitic patients, there was a collapse of virgin CD4(+) and CD8(+) T-cell subsets; and, an expansion of activated CD4(+) T-cells. The above abnormalities were mainly restricted to ascitic patients with high serum levels of lypolysaccharide-binding-protein. Norfloxacin normalized the number of monocytes, reduced their activated phenotype and ability to produce TNFalpha and improved the abnormal T-cell homeostasis.
CONCLUSIONS: In ascitic cirrhosis with high lipolysaccharide-binding-protein, monocytes are spontaneously activated to produce TNFalpha and are major contributors to the elevated serum TNFalpha. The T-cell compartment is profoundly depleted. Enteric bacterial products play a relevant role in these immune cellular abnormalities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15030978     DOI: 10.1016/j.jhep.2003.12.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  39 in total

Review 1.  Infection, coagulation, and variceal bleeding in cirrhosis.

Authors:  U Thalheimer; C K Triantos; D N Samonakis; D Patch; A K Burroughs
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

2.  Selective Intestinal Decontamination in Portal Hypertension.

Authors:  William Kemp; Jaye Chin-Dusting
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-01

Review 3.  Altered Microbiome in Patients With Cirrhosis and Complications.

Authors:  Chathur Acharya; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-09       Impact factor: 11.382

4.  Severity of Systemic Inflammatory Response Syndrome Affects Outcomes in Decompensated Cirrhotics with Spontaneous Bacterial Peritonitis.

Authors:  Jennifer D Twilla; Satheesh P Nair; Manish Talwar; Alexander Kovalic; Sanjaya K Satapathy
Journal:  Am J Gastroenterol       Date:  2016-07       Impact factor: 10.864

Review 5.  Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.

Authors:  Louise Madeleine Risør; Flemming Bendtsen; Søren Møller
Journal:  Hepatol Int       Date:  2014-09-27       Impact factor: 6.047

6.  Expression of beta2-integrin on leukocytes in liver cirrhosis.

Authors:  Anatol Panasiuk; Janusz Zak; Elzbieta Maciorkowska; Bozena Panasiuk; Danuta Prokopowicz
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

7.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

8.  Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?

Authors:  Maria Papp; Gary L Norman; Zsuzsanna Vitalis; Istvan Tornai; Istvan Altorjay; Ildiko Foldi; Miklos Udvardy; Zakera Shums; Tamas Dinya; Peter Orosz; Bela Lombay; Gabriella Par; Alajos Par; Gabor Veres; Timea Csak; Janos Osztovits; Ferenc Szalay; Peter Laszlo Lakatos
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

9.  Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis.

Authors:  M Márquez; C Fernández-Gutiérrez; M Montes-de-Oca; M J Blanco; F Brun; C Rodríguez-Ramos; J A Girón-González
Journal:  Clin Exp Immunol       Date:  2009-07-23       Impact factor: 4.330

Review 10.  Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.

Authors:  Jane Macnaughtan; Rajiv Jalan
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.